Rapid herpes test ARIES®

HSVcutaneouscerebrospinal fluid

HSV 1 and HSV 2 are common human pathogens that cause incurable infections in neonates, children and adults worldwide. Combined, HSV infections affect 50 million people in the United States and cause more than one million new infections every year.1 HSV 1 is generally associated with infections in the tongue, mouth, lips, pharynx, and eyes, whereas HSV 2 is primarily associated with genital and neonate infections. Viral isolation, direct or indirect fluorescent antibody testing, in situ hybridization, and serology can be used to diagnose HSV infections.2 However, due to the length of culture time, sample transport difficulties, procedural complexity, and a lack of desirable sensitivity, nucleic acid amplification methods such as PCR are often preferred as the diagnostic test method.3, 4 ARIES® HSV 1&2 Assay (CE-IVD) The ARIES® HSV 1&2 Assay (CE-IVD) is a rapid molecular method for the detection and differentiation of Herpes Simplex Virus 1 and 2 (HSV 1 and 2) in cutaneous or mucocutaneous lesion specimens and cerebrospinal fluid (CSF) using the ARIES® sample-to-answer System. This assay offers: High Sensitivity: Reduces the risk of false negatives and thus improves diagnosic accuracy. High Accuracy: Confidence in results gives patients and clinicians peace of mind, and helps ensure correct treatment. Fast Time to Results: Answers in as little as two hours will allow physicians to quickly optimize therapeutic decisions in the management of suspected HSV infections. Fully Integrated: STAT testing availability ensures results when needed.